Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
Victory RS Select Growth C RSGFX
- NAV / 1-Day Return 10.85 / +0.09 %
- Total Assets 102.8 Mil
-
Adj. Expense Ratio
- Expense Ratio 2.180%
- Distribution Fee Level High
- Share Class Type Level Load
- Category Mid-Cap Growth
- Investment Style Small Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield —
- Turnover 137%
USD | NAV as of Mar 29, 2024 | 1-Day Return as of Mar 29, 2024, 12:14 AM GMT+0
Morningstar’s Analysis RSGFX
Will RSGFX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 25.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Dynatrace Inc Ordinary Shares | 4.06 | 3.9 Mil | Technology |
MACOM Technology Solutions Holdings Inc | 3.14 | 3.0 Mil | Technology |
Cash | 2.98 | 2.9 Mil | Cash and Equivalents |
Apellis Pharmaceuticals Inc | 2.59 | 2.5 Mil | Healthcare |
Check Point Software Technologies Ltd | 2.58 | 2.5 Mil | Technology |
Clean Harbors Inc | 2.43 | 2.3 Mil | Industrials |
Five9 Inc | 2.33 | 2.2 Mil | Technology |
Amicus Therapeutics Inc | 2.32 | 2.2 Mil | Healthcare |
Exact Sciences Corp | 2.23 | 2.2 Mil | Healthcare |
YETI Holdings Inc | 2.14 | 2.1 Mil | Consumer Cyclical |